Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 511,600 | 523,500 | 470,200 | 448,600 | 452,200 |
| Cost of Goods | 423,000 | 429,100 | 387,200 | 366,700 | 372,200 |
| Gross Profit | 88,600 | 94,400 | 83,000 | 81,900 | 80,000 |
| Operating Expenses | 71,800 | 81,800 | 66,100 | 92,300 | 69,900 |
| Operating Income | 16,800 | 12,700 | 17,100 | -9,700 | 10,300 |
| Interest Expense | 1,400 | 3,000 | 2,100 | 2,300 | 2,500 |
| Other Income | 0 | 0 | -4,300 | 0 | 0 |
| Pre-tax Income | 15,400 | 9,700 | 10,700 | -12,000 | 7,800 |
| Income Tax | 5,800 | 6,500 | 2,200 | -2,300 | 3,000 |
| Net Income Continuous | 9,600 | 3,200 | 8,500 | -9,700 | 4,800 |
| Net Income | $9,600 | $3,200 | $8,500 | $-9,700 | $4,800 |
| EPS Basic Total Ops | 0.32 | 0.11 | 0.28 | -0.32 | 0.16 |
| EPS Basic Continuous Ops | 0.32 | 0.11 | 0.28 | -0.32 | 0.16 |
| EPS Diluted Total Ops | 0.31 | 0.10 | 0.28 | -0.32 | 0.16 |
| EPS Diluted Continuous Ops | 0.31 | 0.11 | 0.28 | -0.32 | 0.16 |
| EBITDA(a) | $29,300 | $25,100 | $27,400 | $0 | $20,200 |